![Louise Bak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Louise Bak
Algemeen Adviseur bij
CESSATECH A/S
Profiel
Louise Bak currently works at Cessatech A, as Head-Regulatory Affairs from 2021.
Ms. Bak also formerly worked at IWA Consulting Aps, as Head-Medical Affairs & Market Access from 2018 to 2019 and Glaxo Smith Kline Consumer Sri Lanka, as Regulatory Manager in 2019.
Ms. Bak received her graduate degree in 2010 from the University of Copenhagen and undergraduate degree in 2007 from Danmarks Farmaceutiske Universitet.
Actieve functies van Louise Bak
| Bedrijven | Functie | Begin |
|---|---|---|
| CESSATECH A/S | Algemeen Adviseur | 01-06-2021 |
Eerdere bekende functies van Louise Bak
| Bedrijven | Functie | Einde |
|---|---|---|
Glaxo Smith Kline Consumer Sri Lanka | Algemeen Adviseur | 01-10-2019 |
IWA Consulting Aps
 IWA Consulting Aps Miscellaneous Commercial ServicesCommercial Services Provides regulatory affairs services | Corporate Officer/Principal | 01-06-2019 |
Opleiding van Louise Bak
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Danmarks Farmaceutiske Universitet
 Danmarks Farmaceutiske Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IWA Consulting Aps
IWA Consulting Aps Miscellaneous Commercial ServicesCommercial Services Provides regulatory affairs services | Commercial Services |
Glaxo Smith Kline Consumer Sri Lanka | |
Cessatech A/S
 Cessatech A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for children for the treatment of pediatric acute pain | Health Technology |
